Copyright
©The Author(s) 2025.
World J Hepatol. Nov 27, 2025; 17(11): 113756
Published online Nov 27, 2025. doi: 10.4254/wjh.v17.i11.113756
Published online Nov 27, 2025. doi: 10.4254/wjh.v17.i11.113756
Table 1 The function of short-chain fatty acids in immune regulation during metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis
| SCFAs | Immune cells | Function | Ref. |
| Acetate | Macrophages | A lower dose (0.1 mmol/L) of sodium acetate promotes macrophage inflammation (RAE264.7 cells and Kupffer cells) by promoting the phosphorylation of NF-κB p65 and c-Jun (transcription factor Jun), whereas a higher dose (2 mmol/L) of sodium acetate showed the opposite effect | [39] |
| Acetate | Macrophages | Sodium acetate-loaded liposomes effectively inhibited lipopolysaccharide-activated Kupffer cell proinflammation | [41] |
| Acetate | CD8+ T cells | Acetate can promote the conversion of liver-resident CXCR6+ CD8+ T cells to cytotoxic, auto-aggressive CD8+ T cells in MASH liver, promoting liver damage | [42] |
| Butyrate | Macrophages | Sodium butyrate can inhibit hepatic monocyte-derived macrophage infiltration and promote the apoptosis of proinflammatory M1 macrophages while activating the M2-like macrophages in MASH livers, thereby leading to the healing process | [44] |
| Butyrate | NK cells | Gut bacteria-derived butyrate can promote the maturation of mouse and human liver-resident NK cells by increasing the expression levels of IFN-γ and CD107a, through IL-18 production in hepatocytes and Kupffer cells | [45] |
| Butyrate | CD8+ T cells | Gut microbiota-induced butyrate is responsible for the successful transition from activated CD8+ T cells to memory CD8+ T cells and maintains the survival of memory precursors of CD8+ T cells | [47] |
| Butyrate | CD4+ T cells | Sodium butyrate can promote CD4+ T cell differentiation towards Th2, Th22, and Tregs | [54] |
| Propionate | Macrophages | Propionic acid can suppress M1 macrophage polarization by inhibiting MAPK signaling pathway | [55] |
| Propionate | γδ T cells | Propanoic acid derived from gut microbiota can suppress liver inflammation by decreasing the IL-17-producing γδ T cells | [56] |
| Propionate | T helper cells | Propionate alone or in combination with acetate reduced the numbers of Th1 and Th17 cells and increased the number of Tregs in the spleens and mesenteric lymph nodes of HFD-fed mice | [64] |
Table 2 Clinical trials in the treatment of metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis
| Clinical trials | Phase | Disease | Treatment | Measurements |
| NCT05654805 | N/A | MASLD | Oat-fiber supplementation | Fermentation to short-chain fatty acids (SCFAs) |
| NCT05523024 | N/A | MASLD | Dietary supplementation of probiotics; Dietary supplementation of Berberine; Dietary supplementation of Probiotics and Berberine | The concentrations of SCFAs in stool |
| NCT05402449 | N/A | MASLD | Dietary supplementation of probiotics, including Lactobacillus reuteri GMNL-263 (heat-killed) and GMNL-89 (alive), and Lactobacillus rhamnosus GMNL-74 (alive) | Concentrations of SCFAs in blood |
| NCT04594954 | N/A | MASLD | Fecal microbiota transplantation | Production of SCFAs |
| NCT04415632 | N/A | MASLD | Low glycemic index diet; High glycemic index diet | Plasma concentrations of SCFAs |
| NCT04117802 | N/A | MASLD | Maple syrup | Change of fecal SCFAs |
| NCT01856465 | N/A | MASLD | Bariatric surgery | Change of fecal SCFAs |
| NCT05463575 | 2 | MASLD | Ketohexokinase inhibition | Change of fecal SCFAs, including acetate, propionate, and butyrate |
| NCT05821010 | 2 | MASH | Lyophilized fecal microbiota transplantation capsules Anaerobutyricum soehngenii; Pasteurized Akkermansia muciniphila; Bifidobacterium animalis subsp. Lactis; Fructo-oligosaccharides | Concentrations of SCFAs in blood (i.e., acetate, butyrate, and propionate) |
| NCT05647915 | 4 | Obesity MASLD | Berberine plus lifestyle intervention | Change of SCFAs |
| NCT04465032 | 4 | MASLD | Gut microbiome transplantation | Production of SCFAs |
- Citation: Zhang CY, Liu S, Sui YX, Yang M. Roles of short-chain fatty acids in metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis. World J Hepatol 2025; 17(11): 113756
- URL: https://www.wjgnet.com/1948-5182/full/v17/i11/113756.htm
- DOI: https://dx.doi.org/10.4254/wjh.v17.i11.113756
